Literature DB >> 22786556

Jointly modeling the relationship between longitudinal and survival data subject to left truncation with applications to cystic fibrosis.

Annalisa V Piccorelli1, Mark D Schluchter.   

Abstract

Numerous methods for joint analysis of longitudinal measures of a continuous outcome y and a time to event outcome T have recently been developed either to focus on the longitudinal data y while correcting for nonignorable dropout, to predict the survival outcome T using the longitudinal data y, or to examine the relationship between y and T. The motivating problem for our work is in joint modeling of the serial measurements of pulmonary function (FEV1% predicted) and survival in cystic fibrosis (CF) patients using registry data. Within the CF registry data, an additional complexity is that not all patients have been followed from birth; therefore, some patients have delayed entry into the study while others may have been missed completely, giving rise to a left truncated distribution. This paper shows in joint modeling situations where y and T are not independent, that it is necessary to account for this left truncation to obtain valid parameter estimates related to both survival and the longitudinal marker. We assume a linear random effects model for FEV1% predicted, where the random intercept and slope of FEV1% predicted, along with a specified transformation of the age at death follow a trivariate normal distribution. We develop an expectation-maximization algorithm for maximum likelihood estimation of parameters, which takes left truncation and right censoring of survival times into account. The methods are illustrated using simulation studies and using data from CF patients in a registry followed at Rainbow Babies and Children's Hospital, Cleveland, OH.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22786556      PMCID: PMC5551379          DOI: 10.1002/sim.5469

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  16 in total

Review 1.  Handling drop-out in longitudinal studies.

Authors:  Joseph W Hogan; Jason Roy; Christina Korkontzelou
Journal:  Stat Med       Date:  2004-05-15       Impact factor: 2.373

2.  Methods for the analysis of informatively censored longitudinal data.

Authors:  M D Schluchter
Journal:  Stat Med       Date:  1992 Oct-Nov       Impact factor: 2.373

3.  Spirometric reference values from a sample of the general U.S. population.

Authors:  J L Hankinson; J R Odencrantz; K B Fedan
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

4.  Mixture models for the joint distribution of repeated measures and event times.

Authors:  J W Hogan; N M Laird
Journal:  Stat Med       Date:  1997 Jan 15-Feb 15       Impact factor: 2.373

5.  Estimation and comparison of changes in the presence of informative right censoring: conditional linear model.

Authors:  M C Wu; K R Bailey
Journal:  Biometrics       Date:  1989-09       Impact factor: 2.571

6.  An approximate generalized linear model with random effects for informative missing data.

Authors:  D Follmann; M Wu
Journal:  Biometrics       Date:  1995-03       Impact factor: 2.571

7.  Modelling progression of CD4-lymphocyte count and its relationship to survival time.

Authors:  V De Gruttola; X M Tu
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

8.  Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis.

Authors:  M Corey; L Edwards; H Levison; M Knowles
Journal:  J Pediatr       Date:  1997-12       Impact factor: 4.406

9.  Pulmonary function between 6 and 18 years of age.

Authors:  X Wang; D W Dockery; D Wypij; M E Fay; B G Ferris
Journal:  Pediatr Pulmonol       Date:  1993-02

10.  Jointly modelling the relationship between survival and pulmonary function in cystic fibrosis patients.

Authors:  Mark D Schluchter; Michael W Konstan; Pamela B Davis
Journal:  Stat Med       Date:  2002-05-15       Impact factor: 2.373

View more
  9 in total

1.  Developmental considerations in survival models as applied to substance use research.

Authors:  Kristina M Jackson; Tim Janssen
Journal:  Addict Behav       Date:  2018-11-20       Impact factor: 3.913

Review 2.  Use of FEV1 in cystic fibrosis epidemiologic studies and clinical trials: A statistical perspective for the clinical researcher.

Authors:  Rhonda Szczesniak; Sonya L Heltshe; Sanja Stanojevic; Nicole Mayer-Hamblett
Journal:  J Cyst Fibros       Date:  2017-01-20       Impact factor: 5.482

3.  Dynamics of Disease Progression and Gastrostomy Tube Placement in Children and Adolescents with Cystic Fibrosis: Application of Joint Models for Longitudinal and Time-to-Event Data.

Authors:  Rhonda Szczesniak; Weiji Su; J P Clancy
Journal:  Intern Med Rev (Wash D C)       Date:  2016-10

4.  Shared parameter models for joint analysis of longitudinal and survival data with left truncation due to delayed entry - Applications to cystic fibrosis.

Authors:  Mark D Schluchter; Annalisa V Piccorelli
Journal:  Stat Methods Med Res       Date:  2018-04-04       Impact factor: 3.021

5.  Joint modelling of longitudinal and survival data: incorporating delayed entry and an assessment of model misspecification.

Authors:  Michael J Crowther; Therese M-L Andersson; Paul C Lambert; Keith R Abrams; Keith Humphreys
Journal:  Stat Med       Date:  2015-10-29       Impact factor: 2.373

6.  Multivariate joint modeling to identify markers of growth and lung function decline that predict cystic fibrosis pulmonary exacerbation onset.

Authors:  E R Andrinopoulou; J P Clancy; R D Szczesniak
Journal:  BMC Pulm Med       Date:  2020-05-19       Impact factor: 3.317

7.  Integrating latent classes in the Bayesian shared parameter joint model of longitudinal and survival outcomes.

Authors:  Eleni-Rosalina Andrinopoulou; Kazem Nasserinejad; Rhonda Szczesniak; Dimitris Rizopoulos
Journal:  Stat Methods Med Res       Date:  2020-05-21       Impact factor: 3.021

8.  Flexible semiparametric joint modeling: an application to estimate individual lung function decline and risk of pulmonary exacerbations in cystic fibrosis.

Authors:  Dan Li; Ruth Keogh; John P Clancy; Rhonda D Szczesniak
Journal:  Emerg Themes Epidemiol       Date:  2017-11-14

Review 9.  Harnessing repeated measurements of predictor variables for clinical risk prediction: a review of existing methods.

Authors:  Lucy M Bull; Mark Lunt; Glen P Martin; Kimme Hyrich; Jamie C Sergeant
Journal:  Diagn Progn Res       Date:  2020-07-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.